10x Genomics Showcases Robust Innovation Pipeline at Xperience 2022 Event

PLEASANTON, Calif: PLEASANTON, Calif,, Feb. 22, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today unveiled new details about upcoming products and capabilities across its single cell, spatial, and in situ platforms at its second annual Xperience 2022...

Click to view original post